{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Gina", "organization": "", "rank": 1, "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "news_desk": "National", "slideshow_credits": null, "abstract": "Pfizer-funded study by Dr Steven Nissen of Cleveland Clinic published in New England Journal of Medicine indicates prescription-only, anti-inflammatory medication celecoxib is safer for patients with heart problems than naproxen or ibuprofen; decade-long research involved 24,000 patients with arthritis who had or were at high risk for heart disease; findings may increase prescriptions of celecoxib for long-term use because it does not appear to cause gastrointestinal bleeding.", "multimedia": [{"type": "image", "url": "images/2016/11/13/us/14heart/14heart-thumbWide.jpg", "legacy": {"wide": "images/2016/11/13/us/14heart/14heart-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/11/13/us/14heart/14heart-articleLarge.jpg", "legacy": {"xlarge": "images/2016/11/13/us/14heart/14heart-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "540"}, "width": 600, "subtype": "xlarge", "height": 540}, {"type": "image", "url": "images/2016/11/13/us/14heart/14heart-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/11/13/us/14heart/14heart-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs", "main": "Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs"}, "print_page": "20", "keywords": [{"value": "Celebrex (Drug)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Pfizer Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Clinical Trials", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Heart", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Arthritis", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Ibuprofen (Drug)", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "New England Journal of Medicine", "is_major": "Y", "rank": "8", "name": "organizations"}], "snippet": "A question has long hung over Celebrex: Did it cause heart attacks? Now, a clinical trial suggests it may be safer than drugs like ibuprofen and naproxen....", "source": "The New York Times", "lead_paragraph": "A question has long hung over Celebrex: Did it cause heart attacks? Now, a clinical trial suggests it may be safer than drugs like ibuprofen and naproxen.", "word_count": "1127", "pub_date": "2016-11-13T21:45:13Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Health", "web_url": "http://www.nytimes.com/2016/11/14/health/celebrex-is-found-to-be-no-riskier-for-hearts-than-other-pain-drugs.html", "_id": "5828def17c459f6a5fccdc04"}